Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
Hu Li Za Zhi the Journal of Nursing
|
April 10, 2015
[Nursing care of chemotherapy-induced peripheral neuropathy]
Shu-Yi Hsu, Chang-Hsien Lu, Shu-Zhen Chen, et al.
Zhonghua Yi Xue Za Zhi
|
February 23, 2007
[Erythromycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs]
Shu-zhen Chen, Sheng-hua Zhang, Jian-hua Gong, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|
November 30, 2011
[Lidamycin metabolism in vitro]
Yan-qing Wen, Zhi-yun Meng, Shu-zhen Chen, et al.
Journal of Clinical Ultrasound : JCU
|
December 10, 2021
The necessity of transperineal ultrasound view in urethra malacoplakia
Xin Wang, Qian Wang, Shu-Zhen Chen, et al.
Life Sciences
|
July 5, 2020
Levamisole enhances DR4-independent apoptosis induced by TRAIL through inhibiting the activation of JNK in lung cancer
Xinran Qiao, Chen Wang, Wendie Wang, et al.
Oncology Reports
|
April 30, 2010
HERG K+ channel related chemosensitivity to sparfloxacin in colon cancer cells
Jian-Hua Gong, Xiu-Jun Liu, Bo-Yang Shang, et al.
Developmental Biology
|
July 30, 2005
LrrA, a novel leucine-rich repeat protein involved in cytoskeleton remodeling, is required for multicellular morphogenesis in Dictyostelium discoideum
Chia-I Liu, Tsung-Lin Cheng, Shu-Zhen Chen, et al.
Amino Acids
|
February 26, 2017
RGD and NGR modified TRAIL protein exhibited potent anti-metastasis effects on TRAIL-insensitive cancer cells in vitro and in vivo
Xiaofei Wang, Xinran Qiao, Yue Shang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 22, 2022
Thymidine Kinase 1 Mediates the Synergistic Antitumor Activity of Ubenimex and Celecoxib via Regulation of Cell Cycle in Colorectal Cancer
Aimin Wang, Yue Shang, Jun Ni, et al.
Anti-Cancer Drugs
|
August 15, 2014
A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity
Daqiang Zhu, Xiaofei Wang, Yue Shang, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
Hu Li Za Zhi the Journal of Nursing
|
April 10, 2015
[Nursing care of chemotherapy-induced peripheral neuropathy]
Shu-Yi Hsu, Chang-Hsien Lu, Shu-Zhen Chen, et al.
Zhonghua Yi Xue Za Zhi
|
February 23, 2007
[Erythromycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs]
Shu-zhen Chen, Sheng-hua Zhang, Jian-hua Gong, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|
November 30, 2011
[Lidamycin metabolism in vitro]
Yan-qing Wen, Zhi-yun Meng, Shu-zhen Chen, et al.
Journal of Clinical Ultrasound : JCU
|
December 10, 2021
The necessity of transperineal ultrasound view in urethra malacoplakia
Xin Wang, Qian Wang, Shu-Zhen Chen, et al.
Life Sciences
|
July 5, 2020
Levamisole enhances DR4-independent apoptosis induced by TRAIL through inhibiting the activation of JNK in lung cancer
Xinran Qiao, Chen Wang, Wendie Wang, et al.
Oncology Reports
|
April 30, 2010
HERG K+ channel related chemosensitivity to sparfloxacin in colon cancer cells
Jian-Hua Gong, Xiu-Jun Liu, Bo-Yang Shang, et al.
Developmental Biology
|
July 30, 2005
LrrA, a novel leucine-rich repeat protein involved in cytoskeleton remodeling, is required for multicellular morphogenesis in Dictyostelium discoideum
Chia-I Liu, Tsung-Lin Cheng, Shu-Zhen Chen, et al.
Amino Acids
|
February 26, 2017
RGD and NGR modified TRAIL protein exhibited potent anti-metastasis effects on TRAIL-insensitive cancer cells in vitro and in vivo
Xiaofei Wang, Xinran Qiao, Yue Shang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 22, 2022
Thymidine Kinase 1 Mediates the Synergistic Antitumor Activity of Ubenimex and Celecoxib via Regulation of Cell Cycle in Colorectal Cancer
Aimin Wang, Yue Shang, Jun Ni, et al.
Anti-Cancer Drugs
|
August 15, 2014
A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity
Daqiang Zhu, Xiaofei Wang, Yue Shang, et al.
Page
of 6